Propagation of Tau Pathology in a Model of Early Alzheimer's Disease

de Calignon, Alix, Polydoro, Manuela, Suárez-Calvet, Marc, William, Christopher, Adamowicz, David H., Kopeikina, Kathy J., Pitstick, Rose, Sahara, Naruhiko +4 more·2012·Neuron
DOI 10.1016/j.neuron.2011.11.033

Cited by (1,003)

Items 801–900 of 1,003

  1. Detecting tau in serum of transgenic animal models after tau immunotherapy treatment
    Cristina d’Abramo, Christopher M. Acker, Joel B. Schachter, Giuseppe Terracina, Xiaohai Wang, Stefanie K. Forest, Peter Davies · 2015 · Neurobiology of Aging
  2. The CNS in inbred transgenic models of 4-repeat Tauopathy develops consistent tau seeding capacity yet focal and diverse patterns of protein deposition
    Eskandari-Sedighi, Ghazaleh, Daude, Nathalie, Gapeshina, Hristina, Sanders, David W., Kamali-Jamil, Razieh, Yang, Jing, Shi, Beipei, Wille, Holger, Ghetti, Bernardino, Diamond, Marc I. et al. · 2017 · Molecular Neurodegeneration
  3. Four-month treadmill exercise prevents the decline in spatial learning and memory abilities and the loss of spinophilin-immunoreactive puncta in the hippocampus of APP/PS1 transgenic mice
    Lei Zhang, Wei Xue Tang, Feng‐lei Chao, Chunni Zhou, Lin Hong Jiang, Yi Zhang, Xin Liang, Jing Tang, Yingqiang Qi, Hao Yang et al. · 2019 · Neurobiology of Disease
  4. Graph Models of Pathology Spread in Alzheimer's Disease: An Alternative to Conventional Graph Theoretic Analysis
    Ashish Raj · 2021 · Brain Connectivity
  5. Tau Secretion
    Zhi Ruan, Tsuneya Ikezu · 2019 · Advances in experimental medicine and biology
  6. Future Directions in Imaging Neurodegeneration
    Joseph C. Masdeu · 2017 · Current Neurology and Neuroscience Reports
  7. Cellular Models for the Study of Prions
    Brandon B. Holmes, Marc I. Diamond · 2016 · Cold Spring Harbor Perspectives in Medicine
  8. Potential Mechanisms of Tunneling Nanotube Formation and Their Role in Pathology Spread in Alzheimer’s Disease and Other Proteinopathies
    Szymon Kotarba, Marta Kozłowska, Małgorzata Scios, Kamil Saramowicz, Julia Barczuk, Zuzanna Granek, Natalia Siwecka, Wojciech Wiese, Michał Golberg, Grzegorz Galita et al. · 2024 · International Journal of Molecular Sciences
  9. Alzheimer's Disease and Frontotemporal Dementia: A Review of Pathophysiology and Therapeutic Approaches
    Sally Kelliny, Xin‐Fu Zhou, Larisa Bobrovskaya · 2025 · Journal of Neuroscience Research
  10. Longitudinal predictive modeling of tau progression along the structural connectome
    Fan Yang, Samadrita Roy Chowdhury, Heidi I.L. Jacobs, Jorge Sepulcre, Van Jay Wedeen, Keith A. Johnson, Joyita Dutta · 2021 · NeuroImage
  11. Astrocytes in Neurodegenerative Diseases: A Perspective from Tauopathy and α-Synucleinopathy
    Peng Wang, Yihong Ye · 2021 · Life
  12. Distinct Factors Drive the Spatiotemporal Progression of Tau Pathology in Older Adults
    Jenna N. Adams, Theresa M. Harrison, Anne Maass, Suzanne L. Baker, William J. Jagust · 2021 · Journal of Neuroscience
  13. Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer’s Disease
    Amy R. Nelson · 2022 · Frontiers in Aging Neuroscience
  14. Pathogenic Role of RAGE in Tau Transmission and Memory Deficits
    Youbin Kim, Hyejin Park, Youngwon Kim, Seohyun Kim, Jae‐Hoon Lee, Hanseul Yang, Seo Jin Kim, Cathena Meiling Li, Haneul Lee, Do-Hyeong Na et al. · 2022 · Biological Psychiatry
  15. Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective
    Isidró Ferrer · 2022 · Free Neuropathology
  16. Hippocampal phospho-tau/MAPT neuropathology in the fornix in Alzheimer disease: an immunohistochemical autopsy study
    Edward D. Plowey, Jennifer L. Ziskin · 2016 · Acta Neuropathologica Communications
  17. Pathogenic tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathways
    Kyle R. Christensen, Thomas G. Beach, Geidy E. Serrano, Nicholas M. Kanaan · 2019 · Acta Neuropathologica Communications
  18. Astrocyte transport of glutamate and neuronal activity reciprocally modulate tau pathology in Drosophila
    Jason Kilian, Heng-Wei Hsu, Kenneth Mata, Fred W. Wolf, Masashi Kitazawa · 2017 · Neuroscience
  19. Neuronal Vulnerability of the Entorhinal Cortex to Tau Pathology in Alzheimer’s Disease
    Simi Zhang, Chelsea Ann Crossley, Qi Yuan · 2024 · British Journal of Biomedical Science
  20. Harnessing the Immune System for Treatment and Detection of Tau Pathology
    Erin E. Congdon, Senthilkumar Krishnaswamy, Einar M. Sigurdsson · 2014 · Journal of Alzheimer s Disease
  21. Transfer of pathogenic and nonpathogenic cytosolic proteins between spinal cord motor neurons in vivo in chimeric mice
    Eleanor V. Thomas, Wayne A. Fenton, James M. McGrath, Arthur L. Horwich · 2017 · Proceedings of the National Academy of Sciences
  22. Gut Microbiota and Immunotherapy for Alzheimer’s Disease
    Chun‐Ling Dai, Fei Liu, Khalid Iqbal, Cheng‐Xin Gong · 2022 · International Journal of Molecular Sciences
  23. Targeted protein degradation for the treatment of Parkinson’s disease: Advances and future perspective
    Roshanak Amirian, Mehdi Azadi Badrbani, Hossein Derakhshankhah, Zhila Izadi, Mohammad‐Ali Shahbazi · 2023 · Biomedicine & Pharmacotherapy
  24. Tau–amyloid interactions in the rTgTauEC model of early Alzheimer's disease suggest amyloid‐induced disruption of axonal projections and exacerbated axonal pathology
    Amy M. Pooler, Manuela Polydoro, Susanne Wegmann, Rose Pitstick, Kevin R. Kay, Laura Sanchez, George A. Carlson, Teresa Gómez‐Isla, Mark W. Albers, Tara L. Spires‐Jones et al. · 2013 · The Journal of Comparative Neurology
  25. Ataxin-1 oligomers induce local spread of pathology and decreasing them by passive immunization slows Spinocerebellar ataxia type 1 phenotypes
    Cristian A. Lasagna‐Reeves, Maxime W.C. Rousseaux, Marcos Jair Guerrero‐Munoz, Luis Vilanova-Velez, Jeehye Park, Lauren See, Paymaan Jafar‐Nejad, Ronald Richman, Harry T. Orr, Rakez Kayed et al. · 2015 · eLife
  26. Neurodegenerative disorders share common features of “loss of function” states of a proposed mechanism of nervous system functions
    Kunjumon I. Vadakkan · 2016 · Biomedicine & Pharmacotherapy
  27. Vesicular Glutamate Uptake
    Tetsufumi Ueda · 2016 · Advances in neurobiology
  28. Prion-like transmission of pathogenic protein aggregates in genetic models of neurodegenerative disease
    Margaret M.P. Pearce · 2017 · Current Opinion in Genetics & Development
  29. Tau Spread, Apolipoprotein E, Inflammation, and More
    Bianca L. Gonzalez, Edsel M. Abud, Abigail M. Abud, Wayne W. Poon, Karen H. Gylys · 2017 · Neurologic Clinics
  30. Patient-blood-Management
    Patrick Meybohm, Dania Fischer, A. Schnitzbauer, Andreas Zierer, Thomas Schmitz-Rixen, G. Bartsch, Christof Geisen, K. Zacharowski · 2015 · Der Chirurg
  31. Proteomic screen reveals diverse protein transport between connected neurons in the visual system
    Lucio Schiapparelli, Pranav Sharma, Hai‐yan He, Jianli Li, Sahil Hemant Shah, Daniel B. McClatchy, Yuanhui Ma, Han-Hsuan Liu, Jeffrey Louis Goldberg, John R. Yates et al. · 2022 · Cell Reports
  32. Association of longitudinal cognitive decline with diffusion MRI in gray matter, amyloid, and tau deposition
    Wang, Wei-en, Chen, Rob, Mayrand, Robin Perry, Adjouadi, Malek, Fang, Ruogu, DeKosky, Steven T., Duara, Ranjan, Coombes, Stephen A., Vaillancourt, David E. · 2023 · Neurobiology of Aging
  33. Lack of exon 10 in the murine tau gene results in mild sensorimotor defects with aging
    Astrid Gumucio, Lars Lannfelt, Lars N. G. Nilsson · 2013 · BMC Neuroscience
  34. Highly Specific and Sensitive Target Binding by the Humanized pS396-Tau Antibody hC10.2 Across a Wide Spectrum of Alzheimer’s Disease and Primary Tauopathy Postmortem Brains
    Lone Helboe, Nina Rosenqvist, Christiane Volbracht, Lars Østergaard Pedersen, Jan T. Pedersen, Søren Christensen, Jan Egebjerg, Claus T. Christoffersen, Benny Bang‐Andersen, Thomas G. Beach et al. · 2022 · Journal of Alzheimer s Disease
  35. AD genetic risk factors and tau spreading
    Jesús Ávila, Alberto Gómez‐Ramos, Marta Bolós · 2015 · Frontiers in Aging Neuroscience
  36. Effect of amyloid‐β ( A β) immunization on hyperphosphorylated tau: a potential role for glycogen synthase kinase (GSK )‐3β
    Jay Amin, Claire Paquet, Alex Baker, Ayodeji A. Asuni, Seth Love, Clive Holmes, Jacques Hugon, James A. R. Nicoll, Delphine Boche · 2014 · Neuropathology and Applied Neurobiology
  37. Treatment of Alzheimer’s Disease: Current Management and Experimental Therapeutics
    Lawrence S. Honig, Clara D. Boyd · 2013 · Current Translational Geriatrics and Experimental Gerontology Reports
  38. The Neurogenomics View of Neurological Diseases
    Shoji Tsuji · 2013 · JAMA Neurology
  39. Altered Functional Network Affects Amyloid and Structural Covariance in Alzheimer’s Disease
    Ya‐Ting Chang, Chi‐Wei Huang, Wen‐Neng Chang, Jun‐Jun Lee, Chiung‐Chih Chang · 2018 · BioMed Research International
  40. Intrinsic connectivity identifies the sensory-motor network as a main cross-network between remitted late-life depression- and amnestic mild cognitive impairment-targeted networks
    Jiu Chen, Hao Shu, Zan Wang, Yafeng Zhan, Duan Liu, Yong Liu, Zhijun Zhang · 2019 · Brain Imaging and Behavior
  41. Tau pathology in the medial temporal lobe of athletes with chronic traumatic encephalopathy: a chronic effects of neurotrauma consortium study
    Christy M. Kelley, Sylvia E. Perez, Elliott Jay Mufson · 2019 · Acta Neuropathologica Communications
  42. Distribution of TDP-43 Pathology in Hippocampal Synaptic Relays Suggests Transsynaptic Propagation in Frontotemporal Lobar Degeneration
    Pouya Jamshidi, Garam Kım, Ryan K. Shahidehpour, Kabriya Bolbolan, Tamar D. Gefen, Eileen H. Bigio, Marsel M. Mesulam, Changiz Geula · 2020 · Journal of Neuropathology & Experimental Neurology
  43. Synaptic oligomeric tau in Alzheimer’s disease – a potential culprit in the spread of tau pathology through the brain
    Martí Colom‐Cadena, Caitlin Davies, Sònia Sirisi, Ji-Eun Lee, Elizabeth M. Simzer, Makis Tzioras, Marta Querol‐Vilaseca, Érika Sánchez‐Aced, Ya Yin Chang, Kristján Holt et al. · 2023 · medRxiv
  44. Inflammasome links traumatic brain injury, chronic traumatic encephalopathy, and Alzheimer’s disease
    Gabriela Seplovich, Yazan Bouchi, Juan Pablo de Rivero Vaccari, Jennifer C. Muñoz Pareja, Andrew Reisner, Laura S. Blackwell, Yehia S. Mechref, Kevin Wang, Joseph Adrian Tyndall, Binu Tharakan et al. · 2024 · Neural Regeneration Research
  45. Hyperglycosylation is a metabolic driver of Alzheimer’s disease
    Tara R. Hawkinson, Zizhen Liu, Roberto A. Ribas, Terrymar Medina, Rikke S. Nielsen, Harrison A. Clarke, Xin Ma, Angela C. Mueller, Adrielle F. Plasencia, Alexander L. Sheer et al. · 2026 · Nature Metabolism
  46. Metallothioneins in Prion- and Amyloid-Related Diseases
    Pavlína Adam, Soňa Křížková, Zbyněk Heger, Petr Babula, Vladimír Pekařík, Markéta Vaculovičová, Cláudio M. Gomes, René Kizek, Vojtěch Adam · 2016 · Journal of Alzheimer s Disease
  47. Inflammatory changes in optic nerve after closed-head repeated traumatic brain injury: Preliminary study
    Radouil T. Tzekov, Josie Phifer, April Myers, Benoit Mouzon, Fiona Crawford · 2016 · Brain Injury
  48. Tau13 Antibody Preferentially Immunoprecipitates High Molecular Weight Tau Proteins
    Andrew Umstead, Irving E. Vega · 2019 · Journal of Alzheimer s Disease
  49. Molecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer’s disease
    Fabiha Zaheen Khan, Md Shaki Mostaid, Mohd Nazmul Hasan Apu · 2022 · Heliyon
  50. Dynamic network model reveals distinct tau spreading patterns in early- and late-onset Alzheimer disease
    Wha Jin Lee, Hanna Cho, Min Seok Baek, Han‐Kyeol Kim, Jae‐Hoon Lee, Young Hoon Ryu, Chul Hyoung Lyoo, Joon‐Kyung Seong · 2022 · Alzheimer s Research & Therapy
  51. Tau antibody 77G7 targeting microtubule binding domain suppresses proteopathic tau to seed tau aggregation
    Longfei Li, Jin Miao, Dandan Chu, Nana Jin, Yunn Chyn Tung, Chun‐Ling Dai, Wen Hui Hu, Cheng‐Xin Gong, Khalid Iqbal, Fei Liu · 2022 · CNS Neuroscience & Therapeutics
  52. Numb regulates Tau levels and prevents neurodegeneration in tauopathy mouse models
    Marine Lacomme, Sarah C. Hales, Thomas W. Brown, Katarina Stevanovic, Christine Jolicoeur, Jenny Cai, Thérence Bois, Mélissa Desrosiers, Deniz Dalkara, Michel Cayouette · 2022 · Science Advances
  53. A 3D human co-culture to model neuron-astrocyte interactions in tauopathies
    Kevin Llewelyn Batenburg, Claudia Sestito, Paulien Cornelissen‐Steijger, Jan R.T. van Weering, Leo Price, Vivi Majella Heine, Wiep Scheper · 2023 · Biological Procedures Online
  54. Adult-onset focal expression of mutated human tau in the hippocampus impairs spatial working memory of rats
    Martina L. Mustroph, Michael A. King, Ronald L. Klein, Julio J. Ramirez · 2012 · Behavioural Brain Research
  55. Secretion of full-length Tau or Tau fragments in cell culture models. Propagation of Tau in vivo and in vitro
    Mar Pérez, Miguel Medina, Félix Hernández, Jesús Ávila · 2018 · BioMolecular Concepts
  56. Inhaled Xenon Washout as a Biomarker of Alzheimer’s Disease
    Francis T. Hane, Tao Li, Jennifer Anne Plata, Ayman Ahmed Hassan, Karl Granberg, Mitchell S. Albert · 2018 · Diagnostics
  57. Elevation of casein kinase 1ε associated with TDP‐43 and tau pathologies in Alzheimer's disease
    Jianlan Gu, Wen Hui Hu, Xuefeng Tan, Shuting Qu, Dandan Chu, Cheng‐Xin Gong, Khalid Iqbal, Fei Liu · 2019 · Brain Pathology
  58. Towards Knowledge Maintenance in Scientific Digital Libraries with the Keystone Framework
    Yuanxi Fu, Jodi Schneider · 2020 · ACM/IEEE Joint Conference on Digital Libraries
  59. Pathogenic Tau Protein Species: Promising Therapeutic Targets for Ocular Neurodegenerative Diseases
    Mohammad Amir Mishan, Mozhgan Rezaei Kanavi, Koorosh Shahpasand, Hamid Ahmadieh · 2019 · Journal of Ophthalmic and Vision Research
  60. β-Amyloidosis and neurodegeneration in Alzheimer disease
    D. Knopman · 2014 · Neurology
  61. Analog of kynurenic acid decreases tau pathology by modulating astrogliosis in rat model for tauopathy
    Petra Majerová, Dominika Olešová, Greta Golisova, Martina Buralova, Alena Michalicová, Jozef Vegh, Juraj Piešťanský, Mangesh Ramesh Bhide, Jozef Hanes, Andrej Kováč · 2022 · Biomedicine & Pharmacotherapy
  62. Long COVID could become a widespread post-pandemic disease? A debate on the organs most affected
    Francesco Ferrara, Andrea Zovi, Marta Masi, Roberto Langella, Ugo Trama, Mariarosaria Boccellino, Antonio Vitiello · 2023 · Naunyn-Schmiedeberg s Archives of Pharmacology
  63. TLR2 immunotherapy suppresses neuroinflammation, tau spread, and memory loss in rTg4510 mice
    Youbin Kim, Shin-Hyeon Ryu, Junho Hyun, Y.-J. Cho, Yong‐Keun Jung · 2024 · Brain Behavior and Immunity
  64. Prions and Prion-Like Pathogens in Neurodegenerative Disorders
    Caterina Peggion, Maria Catia Sorgato, Alessandro Bertoli · 2014 · Pathogens
  65. Neurodegenerative disorders: Dysregulation of a carefully maintained balance?
    Chrisna Swart, William Lloyd Haylett, Craig John Kinnear, Glynis Johnson, Soraya Bardien, Ben Loos · 2014 · Experimental Gerontology
  66. Impact of changes in neurotrophic supplementation on development of Alzheimer’s disease-like pathology in OXYS rats
    Ekaterina A. Rudnitskaya, Nataliya G. Kolosova, Natalia A. Stefanova · 2017 · Biochemistry (Moscow)
  67. Emerging links between cell competition and Alzheimer's disease
    Dina S. Coelho, E. Moreno · 2019 · Journal of Cell Science
  68. Prion-Like Propagation Mechanisms in Tauopathies and Traumatic Brain Injury: Challenges and Prospects
    Hadeel Alyenbaawi, W. Ted Allison, Sue‐Ann Mok · 2020 · Biomolecules
  69. Synthetic prions and other human neurodegenerative proteinopathies
    Nhat T. T. Le, Joanna Narkiewicz, Suzana Aulić, Giulia Salzano, Thanh Hoa Tran, Denis Scaini, Fabio Moda, Gabriele Giachin, Giuseppe Legname · 2014 · Virus Research
  70. Endogenous Tau Aggregates in Oligodendrocytes of rTg4510 Mice Induced by Human P301L Tau
    Yan Ren, Wen-Lang Lin, Laura Sanchez, Carolina Ceballos, Manuela Polydoro, Tara L. Spires‐Jones, Bradley T. Hyman, Dennis W. Dickson, Naruhiko Sahara · 2013 · Journal of Alzheimer s Disease
  71. Anti-Tau Antibodies: Hitting the Target
    Todd Eliot Golde, Jada M. Lewis, Nikolaus R. McFarland · 2013 · Neuron
  72. Personalised regional modelling predicts tau progression in the human brain
    Pavanjit Chaggar, Jacob W. Vogel, Alexa Pichet Binette, Travis Thompson, Olof T. Strandberg, Niklas Mattsson, Linda Karlsson, Erik Stomrud, Saâd Jbabdi, Stefano Magon et al. · 2025 · PLoS Biology
  73. Tau Acetylation in Entorhinal Cortex Induces its Chronic Hippocampal Propagation and Cognitive Deficits in Mice
    Xin Wang, En-Jie Liu, Qian Rong Liu, Shihong Li, Ting Li, Qiuzhi Zhou, Yanchao Liu, Huaqiu Zhang, Jian‐Zhi Wang · 2020 · Journal of Alzheimer s Disease
  74. Distinct Factors Drive the Spatiotemporal Progression of Tau Pathology in Older Adults.
    Jenna N. Adams, Theresa M. Harrison, Maaß, Anne, Suzanne L. Baker, William J. Jagust · 2022 · DZNE Pub
  75. Fibril treatment changes protein interactions of tau and α-synuclein in human neurons
    Tagan A. Griffin, Paul D. Schnier, Elisa Cleveland, Robert W. Newberry, Julia Becker, George A. Carlson · 2023 · Journal of Biological Chemistry
  76. Deep learning application for the classification of Alzheimer’s disease using 18F-flortaucipir (AV-1451) tau positron emission tomography
    Sang‐Won Park, Na Young Yeo, Yeshin Kim, Gihwan Byeon, Jae‐Won Jang · 2023 · Scientific Reports
  77. Mathematical models on Alzheimer's disease and its treatment: A review
    Mitali Maji, Subhas Khajanchi · 2025 · Physics of Life Reviews
  78. Physical Exercise Decreases Complement‐Mediated Synaptic Loss and Protects Against Cognitive Impairment by Inhibiting Microglial Tmem9‐ ATP6V0D1 in Alzheimer's Disease
    Shiyin Li, Mingyue Li, Ge Li, Lili Li, Xiaofeng Yang, Zejie Zuo, Liying Zhang, Xiquan Hu, Xiaofei He · 2025 · Aging Cell
  79. Expression of a dominant negative mutant innexin in identified neurons and glial cells reveals selective interactions among gap junctional proteins
    Neema Yazdani, Constantine P. Firme, Eduardo R. Macagno, Michael W. Baker · 2013 · Developmental Neurobiology
  80. The use of mouse models to study cell-to-cell transmission of pathological tau
    Sneha Narasimhan, Virginia M.‐Y. Lee · 2017 · Methods in cell biology
  81. Developmental Pathogenicity of 4-Repeat Human Tau Is Lost with the P301L Mutation in Genetically Matched Tau-Transgenic Mice
    Julia Gamache, Lisa J. Kemper, Elizabeth L. Steuer, Kailee Leinonen-Wright, Jessica M. Choquette, Chris J.W. Hlynialuk, Kellie A. Benzow, Keith A. Vossel, Weiming Xia, Michael D. Koob et al. · 2019 · Journal of Neuroscience
  82. Combination of Ocimum sanctum extract and Levetiracetam ameliorates cognitive dysfunction and hippocampal architecture in rat model of Alzheimer’s disease
    H S Nandini, Kamsagara Linganna Krishna, Chinnappa A. Uthaiah · 2021 · Journal of Chemical Neuroanatomy
  83. Positron Emission Tomography in Animal Models of Tauopathies
    Lei Cao, Yanyan Kong, Bin Ji, Yutong Ren, Yihui Guan, Ruiqing Ni · 2022 · Frontiers in Aging Neuroscience
  84. Unlocking Truths of γ-Secretase In Alzheimer'S Disease: What Is the Translational Potential?
    Michael S. Wolfe · 2014 · Future Neurology
  85. Interactions between heme and tau-derived R1 peptides: binding and oxidative reactivity
    Valentina Pirota, Enrico Monzani, Simone Dell’Acqua, Luigi Casella · 2016 · Dalton Transactions
  86. Novel Cell Model for Tauopathy Induced by a Cell-Permeable Tau-Related Peptide
    John R. Veloria, Lin Li, Gail A. M. Breen, Warren J. Goux · 2017 · ACS Chemical Neuroscience
  87. Regulation of Tau Homeostasis and Toxicity by Acetylation
    Tara E. Tracy, Kathryn C. Claiborn, Li Gan · 2019 · Advances in experimental medicine and biology
  88. Arc mediates intercellular tau transmission via extracellular vesicles
    Mitali Tyagi, Eric de Hoog, Matthew Grega, Kaelan R. Sullivan, Alan Walker, Radhika Chadha, Ava Northrop, Balázs Fábián, Gerhard Hummer, Mónika Fuxreiter et al. · 2026 · Cell
  89. Alternatives to amyloid for Alzheimer's disease therapies—a symposium report
    Jennifer Cable, David M. Holtzman, Bradley T. Hyman, Malú G. Tansey, Marco Colonna, M Kellis, Roberta Dı́az Brinton, Marilyn Albert, Cheryl Lea Wellington, Sangram S. Sisodia et al. · 2020 · Annals of the New York Academy of Sciences
  90. Mutant α-synuclein propagates via the lymphatic system of the brain in the monomeric state
    Kyota Fujita, Hidenori Homma, Meihua Jin, Yuki Yoshioka, Xiaocen Jin, Yuko Saito, Hikari Tanaka, Hitoshi Okazawa · 2023 · Cell Reports
  91. Serotonergic dysfunction may mediate the relationship between alcohol consumption and Alzheimer’s disease
    Samantha R. Pierson, Louis John Kolling, Thomas D. James, Govindhasamy Pushpavathi Selvakumar, Catherine Anne Marcinkiewcz · 2024 · Pharmacological Research
  92. Influence of Tau on Neurotoxicity and Cerebral Vasculature Impairment Associated with Alzheimer’s Disease
    Mashoque Ahmad Rather, Andleeb Khan, Sadaf Jahan, Arif Jamal Siddiqui, Lianchun Wang · 2024 · Neuroscience
  93. A Hypnic Hypothesis of Alzheimer's Disease
    Camilla Neergaard Clark, Jason D. Warren · 2013 · Neurodegenerative Diseases
  94. Challenges in the Neuropathological Diagnosis of Dementias
    K. A. Jellinger · 2012 · International Journal of Neuropathology
  95. Spreading of Pathology in Alzheimer’s Disease
    Zhongyue Lv, Chen‐Chen Tan, Jin‐Tai Yu, Lan Tan · 2017 · Neurotoxicity Research
  96. Macroscopic modelling of Alzheimer’s Disease: difficulties and challenges
    M. Bertsch, B. Franchi, A. Raj, M. Tesi · 2021 · Brain Multiphysics
  97. Localization of PDE4D, HCN1 channels, and mGluR3 in rhesus macaque entorhinal cortex may confer vulnerability in Alzheimer’s disease
    Dibyadeep Datta, Isabella Perone, Yury M. Morozov, Jon I. Arellano, Alvaro Duque, PASKO T. RAKIC, Christopher H. van Dyck, Amy F.T. Arnsten · 2023 · Cerebral Cortex
  98. Tau and neuron aging.
    Jesús Ávila, Elena Gómez de Barreda, Noemí Pallas‐Bazarra, Félix Hernández · 2013 · Europe PMC (PubMed Central)
  99. When amyloids become prions
    Raimon Sabaté · 2014 · Prion
  100. Review: The fate of cell grafts for the treatment of H untington's disease: the post‐mortem evidence
    Giulia Cisbani, Francesca Cicchetti · 2013 · Neuropathology and Applied Neurobiology